- Home
- HTFL vs BCRX Comparison
HTFL vs BCRX Comparison
Compare HTFL & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTFL | BCRX |
|---|---|---|
| Founded | 2007 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | HTFL | BCRX |
|---|---|---|
| Price | $26.91 | $9.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $38.20 | $20.82 |
| AVG Volume (30 Days) | 1.3M | ★ 5.7M |
| Earning Date | 03-18-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | $23.36 | N/A |
| Revenue Next Year | $23.03 | $12.55 |
| P/E Ratio | ★ N/A | $8.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.13 | $6.00 |
| 52 Week High | $41.22 | $11.31 |
Technical Indicators
Market Signals| Indicator | HTFL | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.35 | 72.85 |
| Support Level | $25.56 | $7.99 |
| Resistance Level | $32.52 | N/A |
| Average True Range (ATR) | 1.79 | 0.46 |
| MACD | 0.74 | 0.09 |
| Stochastic Oscillator | 79.04 | 73.96 |
Price Performance
Historical ComparisonAbout HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.